CML resistance to tyrosine kinase inhibitors: how is the laboratory to tell?
Goldman, J.
Laboratory Hematology Official Publication of the International Society for Laboratory Hematology 10(3): 181-184
2004
ISSN/ISBN: 1080-2924 PMID: 15529444 Document Number: 573832
Document emailed within 1 workday
Related Documents
Bagadi, S.; Saikia, T.; Pany, A.; Das, B. 2011: Analysis of ABL Kinase Domain Mutations Conferring Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Cases from India Clinical Laboratory 57(7-8): 619-623Xu, J.; Cao, H. 2013: Molecular mechanism and therapeutic strategy for resistance to tyrosine kinase inhibitors in targeted treatment of gastrointestinal stromal tumors Zhonghua Wei Chang Wai Ke Za Zhi 16(3): 288-291
Levy, B.P.; Rao, P.; Becker, D.J.; Becker, K. 2016: Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors Oncology 30(7): 601-612
Przytulska, J.; Tupikowski, K.; Bednarek-Tupikowska, G. 2014: Thyroid dysfunction in patients treated with tyrosine kinase inhibitors Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(211): 42-44
Pang, S.H.; Guo, Z.R.; Liang, X.T. 1997: Synthesis and biological activity of tyrosine protein kinase inhibitors Yao Xue Xue Bao 32(7): 515-523
Reid, T-Elinor.; Fortunak, J.M.; Wutoh, A.; Simon Wang, X. 2016: Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors Current Topics in Medicinal Chemistry 16(13): 1452-1462
Mahon, F.-X. 2019: When can tyrosine kinase inhibitors be discontinued in patients with chronic myeloid leukemia? Clinical Advances in Hematology and Oncology: H&o 17(2): 101-103
Sheng, J.Z.; Wong, N.S.; Wang, H.X.; Wong, T.M. 1997: Pertussis toxin, but not tyrosine kinase inhibitors, abolishes effects of U-50488H on [Ca2+]i in myocytes American Journal of Physiology 272(2 Pt 1): C560-C564
Jiang, J.-f.; Chen, X.-y.; Zhong, D.-f. 2016: Metabolic research of domestically developed small molecule tyrosine kinase inhibitors Yao Xue Xue Bao 51(2): 248-256
Bhatia, R.; Munthe, H.A.; Verfaillie, C.M. 1998: Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors Leukemia 12(11): 1708-1717
Dou, X.L.; Wang, S.S.; Fang, J.L.; Yu, L.; Ren, X.; Huang, X.J.; Jiang, Q. 2018: Hepatic adverse events associated with tyrosine kinase inhibitors in patients with chronic myeloid leukemia Zhonghua Nei Ke Za Zhi 57(9): 649-655
Aytekin, A.; Ciltas, A.; Sahinli, H.; Benekli, M. 2016: The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases Journal of BUON: Official Journal of the Balkan Union of Oncology 21(1): 281-282
Ghosh, S.; Narla, R.K.; Zheng, Y.; Liu, X.P.; Jun, X.; Mao, C.; Sudbeck, E.A.; Uckun, F.M. 1999: Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents Anti-Cancer Drug Design 14(5): 403-410
2016: (S013) Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma Oncology 30 Suppl
Togashi, Y.; Nishio, K. 2015: Kinase inhibitors and their resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 73(8): 1323-1329
Hargreaves, P.G.; Licking, E.F.; Sargeant, P.; Sage, S.O.; Barnes, M.J.; Farndale, R.W. 1994: The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen Thrombosis and Haemostasis 72(4): 634-642
Morse, M.A. 2001: American Society of Clinical Oncology - 37th Annual Meeting. Small molecule tyrosine kinase inhibitors. 12-15 May 2001, San Francisco, CA, USA IDrugs: the investigational drugs journal 4(8): 857-859
Ruggeri, B.A.; Miknyoczki, S.J.; Singh, J.; Hudkins, R.L. 1999: Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models Current Medicinal Chemistry 6(9): 845-857
Carrera, A.C.; Borlado, L.R.; Roberts, T.M.; Martinez, C. 1994: Tyrosine kinase specific motif at subdomain VIII does not confer specificity for tyrosine Biochemical and Biophysical Research Communications 205(2): 1114-1120
Crowe, A.J.; McGlade, J.; Pawson, T.; Hayman, M.J. 1994: Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase Oncogene 9(2): 537-544